These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity. Fuller RW; Hemrick-Luecke SK J Pharm Pharmacol; 1989 Jul; 41(7):492-3. PubMed ID: 2570859 [TBL] [Abstract][Full Text] [Related]
8. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989 [TBL] [Abstract][Full Text] [Related]
9. The use of the MPTP-treated mouse as an animal model of parkinsonism. Heikkila RE; Sonsalla PK Can J Neurol Sci; 1987 Aug; 14(3 Suppl):436-40. PubMed ID: 3499967 [TBL] [Abstract][Full Text] [Related]
10. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse. Ferraro TN; Golden GT; DeMattei M; Hare TA; Fariello RG Neuropharmacology; 1986 Sep; 25(9):1071-4. PubMed ID: 2430229 [TBL] [Abstract][Full Text] [Related]
11. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1). Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Youngster SK; Sonsalla PK; Heikkila RE J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590 [TBL] [Abstract][Full Text] [Related]
13. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse. Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525 [TBL] [Abstract][Full Text] [Related]
14. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies. Mori S; Fujitake J; Kuno S; Sano Y Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058 [TBL] [Abstract][Full Text] [Related]
16. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets. Perry TL; Jones K; Hansen S; Wall RA Neurosci Lett; 1987 Mar; 75(1):65-70. PubMed ID: 3106859 [TBL] [Abstract][Full Text] [Related]
17. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Hadjiconstantinou M; Mariani AP; Neff NH Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752 [TBL] [Abstract][Full Text] [Related]
18. Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Battaglia G; Busceti CL; Molinaro G; Biagioni F; Storto M; Fornai F; Nicoletti F; Bruno V J Neurosci; 2004 Jan; 24(4):828-35. PubMed ID: 14749427 [TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice. Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]